Real-world adherence, healthcare resource utilization, and costs following a transition to aripiprazole once every 2 months among patients diagnosed with bipolar I disorder in the United States.
- DOI
- 10.3389/fpsyt.2026.1904737
- Published
- 2026
- Container
- Frontiers in psychiatry
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fpsyt.2026.1904737,
title = {Real-world adherence, healthcare resource utilization, and costs following a transition to aripiprazole once every 2 months among patients diagnosed with bipolar I disorder in the United States.},
author = {Nag SS and Urganus A and Bell Lynum KS and Atkins N Jr and Baser O and Rodchenko K and Awasthi S and Harrsen K},
year = {2026},
journal = {Frontiers in psychiatry},
doi = {10.3389/fpsyt.2026.1904737},
url = {https://doi.org/10.3389/fpsyt.2026.1904737}
}RIS
TY - JOUR TI - Real-world adherence, healthcare resource utilization, and costs following a transition to aripiprazole once every 2 months among patients diagnosed with bipolar I disorder in the United States. AU - Nag SS AU - Urganus A AU - Bell Lynum KS AU - Atkins N Jr AU - Baser O AU - Rodchenko K AU - Awasthi S AU - Harrsen K PY - 2026 JO - Frontiers in psychiatry DO - 10.3389/fpsyt.2026.1904737 UR - https://doi.org/10.3389/fpsyt.2026.1904737 ER -
APA
SS, N., A, U., KS, B. L., Jr, A. N., O, B., K, R., S, A., & K, H. (2026). Real-world adherence, healthcare resource utilization, and costs following a transition to aripiprazole once every 2 months among patients diagnosed with bipolar I disorder in the United States.. Frontiers in psychiatry. https://doi.org/10.3389/fpsyt.2026.1904737
Source records
- pubmed · retrieved 2026-09-25T20:52:10.971Z